Today: 7 February 2026
Subscribe
Browse Category

Market Forecasts News 23 December 2025

UiPath Stock (PATH) Slides on Dec. 23, 2025: Today’s Move, Analyst Forecasts, and What Matters Next for 2026

UiPath Stock (PATH) Slides on Dec. 23, 2025: Today’s Move, Analyst Forecasts, and What Matters Next for 2026

UiPath Inc. (NYSE: PATH) is having one of those “welcome to equities” days: after a strong run in December, the automation software company’s shares pulled back sharply in Tuesday trading, even as the broader investment narrative around agentic automation and AI-driven workflow orchestration keeps gaining oxygen. As of Dec. 23, 2025 (19:41 UTC), PATH traded at $15.71, down $0.99 (-5.93%) on the day, after opening near $16.56 and touching an intraday low of $15.69. The drop stands out mostly because it lands right after a surge earlier in December—an upswing that pushed UiPath back into the conversation as a “real
23 December 2025
·····
AppLovin Stock (NASDAQ: APP) Today: Dec. 23, 2025 News, Analyst Forecasts, Price Targets, and 2026 Outlook

AppLovin Stock (NASDAQ: APP) Today: Dec. 23, 2025 News, Analyst Forecasts, Price Targets, and 2026 Outlook

AppLovin Corporation (NASDAQ: APP) stock is taking a breather on Tuesday, December 23, 2025, after a strong run that has made it one of the market’s most closely watched “AI application layer” winners of the past two years. By late morning, APP shares were trading around $713, down roughly 3% on the session, after closing near $734 on Monday. StockAnalysis+1 That pullback comes even as technical analysts point to a fresh breakout attempt and as Wall Street’s longer-term outlook remains broadly constructive, supported by AppLovin’s recent earnings strength, significant buyback capacity, and expanding ambitions beyond gaming into e-commerce and other
23 December 2025
·····
Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Stock (KVUE) News, Forecasts and Analysis for December 23, 2025: Deal Math, Legal Headlines, and What Investors Are Watching

Kenvue Inc. (NYSE: KVUE) is trading in a very particular kind of gravity field on December 23, 2025: part consumer-health staple, part legal-headline lightning rod, and—most importantly right now—part merger-arbitrage instrument because of its pending acquisition by Kimberly-Clark. As of the latest U.S. session data available Tuesday, KVUE traded around $16.98, while Kimberly-Clark (NYSE: KMB) traded around $99.97. That matters because Kenvue shareholders are set to receive $3.50 in cash plus 0.14625 shares of Kimberly-Clark for each Kenvue share at closing, under the announced transaction terms. Kenvue Investors This structure turns KVUE into a living spreadsheet cell: every $1 move
23 December 2025
·······
Micron Technology (MU) Stock on Dec. 23, 2025: AI Memory Crunch, Blowout Guidance, and Fresh Wall Street Price Targets

Micron Technology (MU) Stock on Dec. 23, 2025: AI Memory Crunch, Blowout Guidance, and Fresh Wall Street Price Targets

Micron Technology, Inc. (NASDAQ: MU) is closing out 2025 in the spotlight as investors price in what many analysts are calling a new phase for the historically cyclical memory market—one increasingly tied to AI data-center buildouts, high-bandwidth memory (HBM) supply constraints, and longer-term customer agreements. As of Tuesday, Dec. 23, 2025 (14:16 UTC), Micron shares were trading around $276.59, up about $10.69 from the prior close (roughly +4%). That move caps a week of outsized headlines: record results, aggressive guidance, and a cascade of analyst target hikes—while the broader market braces for thin liquidity into Christmas and a holiday-shortened trading
23 December 2025
·····
Meta Platforms (META) Stock News, Forecasts and Analysis for December 23, 2025: AI Capex, Analyst Targets, and the 2026 Debate

Meta Platforms (META) Stock News, Forecasts and Analysis for December 23, 2025: AI Capex, Analyst Targets, and the 2026 Debate

Meta Platforms, Inc. (NASDAQ: META) stock is heading into the final stretch of 2025 with a familiar tug-of-war: strong advertising momentum and new AI-driven product bets on one side, and intensifying infrastructure spending (and the accounting, regulatory, and legal scrutiny that comes with it) on the other. In early trading on Tuesday, December 23, 2025, Meta shares hovered around $661—a level that keeps the stock in the spotlight as investors weigh the company’s accelerating AI buildout and what it could mean for margins and free cash flow in 2026. MarketWatch+2Yahoo Finance+2 Below is a comprehensive, publication-ready roundup of today’s META
23 December 2025
····
Hycroft Mining (HYMC) Stock Surges on Record Vortex Silver Grades: Latest News, Forecasts, and What to Watch on Dec. 23, 2025

Hycroft Mining (HYMC) Stock Surges on Record Vortex Silver Grades: Latest News, Forecasts, and What to Watch on Dec. 23, 2025

Dec. 23, 2025 — Hycroft Mining Holding Corporation (NASDAQ: HYMC) is back in the spotlight after a sharp move higher tied to fresh drill results at the company’s Hycroft Mine in Nevada. Shares closed up 49.33% on Monday, Dec. 22 at $24.52, following a company update that delivered the highest silver grades reported so far from the Vortex discovery. Nasdaq The rally has quickly turned HYMC into a momentum name again, but the story under the price action is more than a single headline: high-grade exploration success, a 2025 balance-sheet overhaul that left the company debt-free, and a precious-metals tape
23 December 2025
·····
Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts

Eli Lilly Stock (LLY) Outlook on Dec. 23, 2025: Novo’s Wegovy Pill, Lilly’s Next Catalysts, and Wall Street Forecasts

December 23, 2025 — Eli Lilly and Company (NYSE: LLY) is trading around $1,076 as investors digest a fresh competitive jolt in the obesity-drug race: the FDA has approved Novo Nordisk’s first daily oral version of Wegovy. The headline is about Novo, but the market’s real question is about Lilly’s moat: can LLY keep dominating the category while a new “pill era” starts to form? Reuters+1 Why Eli Lilly stock is in focus today: the FDA just green-lit the first oral Wegovy On December 23, Novo Nordisk won U.S. approval for a 25 mg oral Wegovy pill (semaglutide) for chronic
23 December 2025
······
Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

Cemtrex (CETX) Stock News Today: Acquisition Timeline, Dilution Signals, and Fresh Forecasts as Shares Swing Into Dec. 23, 2025

December 23, 2025 — Cemtrex, Inc. (NASDAQ: CETX) is ending the year the way micro-caps often do: loudly. After a sharp, high-volume jump in the latest session, traders are now weighing a cluster of late-2025 catalysts—most notably a near-term aerospace-and-defense acquisition, a new industrial-services LOI, and multiple financing and capital-structure updates that can materially change the share count. SEC+4StockAnalysis+4Cemtrex, Inc.+4 As of early Dec. 23, CETX was indicated around $3.88 in data published by Benzinga (timestamped 5:30 AM EST). Benzinga Below is a complete, up-to-the-minute rundown (as of 23.12.2025) of the news, forecasts, and analyses currently shaping the Cemtrex stock
23 December 2025
·····
Virgin Galactic Stock (SPCE) Today: News, Forecasts, and Analysis for Dec. 23, 2025

Virgin Galactic Stock (SPCE) Today: News, Forecasts, and Analysis for Dec. 23, 2025

Virgin Galactic Holdings, Inc. (NYSE: SPCE) is ending 2025 in a familiar place: high volatility, heavy debate, and a stock chart that looks like it’s been through re-entry. As of Tuesday, December 23, 2025, SPCE is trading around $3.70, after a strong late-December bounce that has put the name back on many traders’ radar—especially those watching short interest, options activity, and the company’s latest financing overhaul. But if you’re trying to understand why the stock has been moving—and what could matter next—the story in late 2025 comes down to three big themes: Below is a detailed, publication-ready roundup of the
23 December 2025
····
Sembcorp Industries Ltd Stock (SGX:U96): Share Price, Alinta Deal Impact, Analyst Forecasts and What Investors Are Watching on Dec. 23, 2025

Sembcorp Industries Ltd Stock (SGX:U96): Share Price, Alinta Deal Impact, Analyst Forecasts and What Investors Are Watching on Dec. 23, 2025

SINGAPORE (Dec. 23, 2025) — Sembcorp Industries Ltd (SGX:U96) is spending late December in a familiar utility-stock paradox: it’s being pitched as a cleaner-energy growth platform because it just agreed to buy an Australian utility that still carries meaningful fossil fuel exposure. The result is a share price caught between two forces — near-term earnings accretion and longer-term transition risk — with analysts splitting on whether the market is being cautious or simply realistic. SG Investors+2MarketScreener+2 Below is what’s driving Sembcorp Industries stock as of 23.12.2025, including the latest company announcements, the most recent broker calls, and where consensus forecasts
23 December 2025
·····
United Overseas Bank (SGX:U11) Stock: Latest News, Forecasts and Analyst Targets as of Dec. 23, 2025

United Overseas Bank (SGX:U11) Stock: Latest News, Forecasts and Analyst Targets as of Dec. 23, 2025

SINGAPORE — Dec. 23, 2025 — United Overseas Bank Limited (UOB) stock is closing out 2025 with two storylines that rarely travel alone: shrinking net interest margins as rates fall, and heightened investor focus on credit quality, particularly where Hong Kong and Greater China property markets remain under stress. Layer on top a fresh bout of “value-unlocking” speculation — UOB is reported to be exploring options for UOB Asset Management — and the result is a stock that’s suddenly back in the centre of Singapore’s big-bank conversation. Reuters+2The Edge Singapore+2 As of Dec. 23, 2025 (13:48 Singapore time), UOB shares
23 December 2025
·····
AppLovin (APP) Stock After Hours (Dec. 22, 2025): Today’s Move, Fresh Forecasts, and What to Watch Before the Market Opens Tuesday

AppLovin (APP) Stock After Hours (Dec. 22, 2025): Today’s Move, Fresh Forecasts, and What to Watch Before the Market Opens Tuesday

AppLovin Corporation (NASDAQ: APP) finished Monday’s session with another step higher—and then largely held steady in after-hours trading as investors head into Tuesday’s open with a packed premarket U.S. data slate and holiday-thinned liquidity. AppLovin stock price after the bell: where APP stands tonight AppLovin closed the regular session on Monday, Dec. 22, 2025 at $733.60, up about 1.7% on the day. Finviz+2StockAnalysis+2 In post-market trading, the stock was little changed, with different quote feeds showing APP hovering around the low-$733 area into the evening (for example, ~$733.15 after hours as of 6:59 p.m. ET on Google Finance). Google The
23 December 2025
···
1 … 4 5 6 7 8 … 34

Stock Market Today

BAT share price closes near 52-week high as buyback rolls on ahead of results week

7 February 2026
London, Feb 7, 2026, 08:12 GMT — Market closed. British American Tobacco shares closed up 1.2% at 4,609 pence on Friday, within touching distance of a 52-week high, after trading between 4,543 and 4,615 pence. The London market is shut for the weekend and reopens on Monday. (Investing.com) The move comes days before BAT’s full-year numbers, a set piece for a stock that trades as much on guidance and cash returns as it does on day-to-day headlines. The company said it will publish preliminary results for the year ended Dec. 31, 2025 on Thursday, Feb. 12, followed by a webcast
Anglo American share price slips as BofA turns neutral after copper outlook cut

Anglo American share price slips as BofA turns neutral after copper outlook cut

7 February 2026
Anglo American shares closed down 0.75% at 3,435 pence Friday after BofA Global Research downgraded the miner to “neutral” and raised its price target to 3,600 pence. Anglo cut its 2026 copper production guidance and warned of continued weakness at De Beers. The company expects $200 million in charges tied to its Chile copper operations in the second half of 2025.
Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

Amazon’s $200B AI Spending Jolt Spurs Stock Selloff as Big Tech Capex Nears $650B

7 February 2026
Amazon shares fell Friday after the company announced a $200 billion AI infrastructure plan for 2026, exceeding analyst expectations and reviving investor concerns about profitability. Combined 2026 capex flagged by Amazon, Alphabet, Microsoft, and Meta now tops $630 billion. Nvidia, AMD, and Broadcom shares surged on the news, while software and data firms remained under pressure.
Go toTop